Status:
COMPLETED
Effects of Salvinorin A in Healthy Controls
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Alliance for Research on Schizophrenia and Depression
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
EARLY_PHASE1
Brief Summary
This study evaluates the effects of Salvinorin A (SA). SA is the active ingredient of the plant Salvia divinorum that is known to have been used by Mexican Indians as part of religious rituals. The pu...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Previous exposure to inhaled Salvinorin A (SA).
Exclusion
Key Trial Info
Start Date :
February 12 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2014
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT00700596
Start Date
February 12 2009
End Date
August 22 2014
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516